Blocking energy production pathways in an aggressive type of brain cancer in children could be a promising new therapeutic ...
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that a study co ...
A Phase 2 clinical trial of investigational product Immune12 is enrolling patients with GBM brain cancer to support ...
Kazia Therapeutics' lead asset, Paxalisib, showed stronger concurrent-control survival data in GBM, but FDA accelerated ...
The screen worked, flagging expected cancer genes. But it also kept returning something that seemed impossible: genes for synapses, glutamate receptors, and neural signaling pathways. “We absolutely ...
Karl Landsteiner University study shows glioblastoma disrupts brain far beyond the tumour: Krems, Austria Friday, April 24, 2026, 09:00 Hrs [IST] Glioblastoma, the most aggressive ...
A groundbreaking nasal drop therapy is offering new hope for glioblastoma patients. This innovative treatment bypasses the blood-brain barrier, directly delivering immune-stimulating compounds to ...
Brain tumors are abnormal growths of cells in or around the brain. They can be primary (originating in the brain) or secondary (metastatic, spreading to the brain from cancer elsewhere). They can also ...
Shropshire's Lingen Davies cancer charity has paid for a number of wellbeing sessions across the county, including yoga and ...